TMEM105 and breast carcinoma: When we investigated the mechanisms by which TMEM105 could mediate glycolysis and regulate BCLM in breast cancer cells, we found the involvement of LDHA, which was a critical component of the glycolytic pathway and played a key role in the proliferation, migration, and chemoresistance of various cancer cells [29–31].